首页> 外文会议>Scientia pharmaceutica >Pharmacokinetic Evaluation of Wheat Germ Agglutinin-Grafted Nanoparticles of Mometasone Furoate
【24h】

Pharmacokinetic Evaluation of Wheat Germ Agglutinin-Grafted Nanoparticles of Mometasone Furoate

机译:小麦胚芽凝集素接枝糠酸莫米松的药代动力学评价

获取原文
获取原文并翻译 | 示例

摘要

The aim of the investigation was to assess the pharmacokinetic parameters of wheat germ agglutinin (WGA)-grafted nanoparticles of mometasone furoate (MF), after intratracheal instillation in rats. PLGA (50:50) nanoparticles (NPs) loaded with MF were prepared by emulsion-solvent evaporation technique. WGA was conjugated to spherical MF loaded nanoparticles by carbodiimide coupling yielding a ligand density of 10-15μg WGA / mg NP. The nanoparticles were characterized for size, zeta potential, entrapment efficiency and in-vitro drug release. Plain drug, MF nanoparticles and WGA-grafted MF nanoparticles were administered intratracheally in rats and at different time intervals drug levels in the lung tissue and bronchoalveolar lavage (BAL) were estimated using HPLC. Cumulative MF-release from unconjugated and conjugated MF-nanoparticles after 2 weeks was 68% and 55% of the initial drug loading. From the lung MF concentration vs time plot, AUC for WGA-MF-NPs and MF-NPs was found to be 5.9 and 3.8 times higher than AUC for plain MF. This improvement of intracellular drug uptake by means of WGA-conjugation might be due to bioadhesive nature of the lectin which provides an intimate contact to lung mucosal cells followed by facilitated transcytosis as confirmed by improved pharmacokinetic behaviour. All in all, these findings are expected to contribute for better management of asthma to overcome the limitation of short lived action associated with dry powder inhalers.
机译:该研究的目的是评估在气管内滴注大鼠后,小麦胚芽凝集素(WGA)移植的糠酸莫米松(MF)纳米颗粒的药代动力学参数。通过乳液-溶剂蒸发技术制备了载有MF的PLGA(50:50)纳米颗粒(NPs)。 WGA通过碳二亚胺偶联偶联到球形MF负载纳米颗粒上,产生10-15μgWGA / mg NP的配体密度。表征纳米颗粒的尺寸,ζ电势,包封效率和体外药物释放。在大鼠中通过气管内施用普通药物,MF纳米颗粒和WGA接枝的MF纳米颗粒,并在不同时间间隔使用HPLC估算肺组织和支气管肺泡灌洗液(BAL)中的药物水平。 2周后未结合的和结合的MF纳米颗粒的MF累积释放量分别为初始药物装载量的68%和55%。从肺部MF浓度与时间的关系图中,发现WGA-MF-NPs和MF-NPs的AUC分别比普通MF的AUC高5.9和3.8倍。通过WGA缀合的细胞内药物摄取的这种改善可能是由于凝集素的生物粘附性质,其提供了与肺粘膜细胞的紧密接触,随后通过改善的药代动力学行为证实了促进的胞吞作用。总而言之,这些发现有望有助于更好地控制哮喘,克服与干粉吸入器相关的短暂作用的局限性。

著录项

  • 来源
    《Scientia pharmaceutica》|2009年|123-132|共10页
  • 会议地点 Vienna(AT)
  • 作者单位

    TIFAC-CORE in NDDS, Pharmacy Department, Faculty of Technology and Engineering, Kalabhavan, The Maharaja Sayajirao University of Baroda, Vadodara 390001, Gujarat, India;

    TIFAC-CORE in NDDS, Pharmacy Department, Faculty of Technology and Engineering, Kalabhavan, The Maharaja Sayajirao University of Baroda, Vadodara 390001, Gujarat, India;

    TIFAC-CORE in NDDS, Pharmacy Department, Faculty of Technology and Engineering, Kalabhavan, The Maharaja Sayajirao University of Baroda, Vadodara 390001, Gujarat, India;

  • 会议组织
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 药学;
  • 关键词

    nanoparticles; mometasone furoate; PolyD,L-lactic acid-co-glycolic acid; sustained delivery; wheat germ agglutinin;

    机译:纳米粒子糠酸莫米松聚[D,L-乳酸-乙醇酸共聚物];持续交付;小麦胚芽凝集素;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号